Three records · four presentation paths
Semaglutide dose chart
Semaglutide is not one interchangeable schedule. The current Wegovy, Ozempic and Rybelsus records differ by product, presentation, route, cadence and dose meaning. CareCanon keeps every path attached to its own label.
- Ingredient
- Semaglutide
- Source labels
- 3 separate records
- Rendered paths
- 4 presentations
- Last mirrored
- 2026-08-29T19:54:30.107Z
Answer first
The product and route come before the milligram number.
The captured records contain two once-weekly injection paths and two once-daily tablet paths. Their starting numbers range from 0.25 mg to 3 mg because the products and routes are not interchangeable.
Do not compare these rows mg-to-mg. This page preserves the published schedule for each presentation; it does not calculate switching, equivalence or a personal dose.
Product-specific schedules
Four paths, never one conversion table.
Every stage below retains its period, dose and phase from the selected source schedule. A later stage is not an instruction to advance, and similarly named stages are not proof of equivalence.
WEGOVY
Injection
- 1 through 40.25 mgStarting Dosage
- 5 through 80.5 mgDosage Escalation
- 9 through 121 mgDosage Escalation
- 13 through 161.7 mgDosage Escalation
- 17 and onwardSee labelMaintenance Dosage
WEGOVY
Tablets
- 1 through 301.5 mgStarting Dosage
- 31 through 604 mgDosage Escalation
- 61 through 909 mgDosage Escalation
- 91 and onward25 mgMaintenance Dosage
OZEMPIC
subcutaneous injection · once weekly
- Weeks 1–40.25 mgStarting dosage
- Weeks 5–80.5 mgDose escalation
- Weeks 9–121 mgDose escalation
- Week 13 onward2 mgMaintenance dosage
RYBELSUS
oral tablet · once daily
- Days 1 through 303 mgStarting dosage
- Days 31 through 607 mgDose escalation
- Day 61 and onward7 mgMaintenance dosage
- Day 61 and onward14 mgMaintenance dosage
Document identity
Three labels power the four paths.
Wegovy contributes two presentation schedules from one current record. Ozempic and Rybelsus retain their own document IDs, publication dates and DailyMed routes.
semaglutide · chronic weight management
WEGOVY
- Label published
- Jun 30, 2026
- Set ID
- ee06186f-2aa3-4990-a760-757579d8f77b
- Rendered paths
- 2
- Mirrored
- 2026-08-29T19:54:27.703Z
semaglutide · type 2 diabetes
OZEMPIC
- Label published
- Jun 10, 2026
- Set ID
- adec4fd2-6858-4c99-91d4-531f5f2a2d79
- Rendered paths
- 1
- Mirrored
- 2026-08-29T19:54:28.918Z
semaglutide · type 2 diabetes (oral)
RYBELSUS
- Label published
- Aug 19, 2026
- Set ID
- 27f15fac-7d98-4114-a2ec-92494a91da98
- Rendered paths
- 1
- Mirrored
- 2026-08-29T19:54:30.107Z
Questions the comparison must answer safely
Name the product before the number.
Is 0.25 mg of injected semaglutide equivalent to 3 mg of Rybelsus?
No equivalence can be inferred from the milligram numbers. The captured records use different products, routes, schedules and prescribing instructions. This page does not calculate or recommend a conversion.
Do Wegovy and Ozempic use the same semaglutide dose schedule?
No. The current Wegovy record contains separate injection and tablet schedules, while the Ozempic record has its own once-weekly injection path and indication-specific dose language.
Why does the current Wegovy record show two schedules?
The captured Wegovy prescribing record includes an injection schedule and a separate once-daily tablet schedule. CareCanon renders both tracks and keeps their units and cadence attached.